Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES-Reference-Cited by-同舟云学术

Tricyclic antidepressant use and the risk of fibrosis progression in hepatitis C-infected persons: Results from ERCHIVES

Author:

Chen J. Y.¹²,Ren Y.³,Yan P.³,Belina M. E.⁴,Chung R. T.⁴,Butt A. A.⁵⁶⁷⁸^ORCID

Affiliation:

1. Department of Medicine; University of California; San Francisco CA USA

2. The Liver Center; University of California; San Francisco CA USA

3. Veterans Research Foundation; Pittsburgh PA USA

4. Gastrointestinal Unit; Harvard Medical School; Massachusetts General Hospital; Boston MA USA

5. VA Pittsburgh Healthcare System; Pittsburgh PA USA

6. Weill Cornell Medical College; Doha Qatar

7. Weill Cornell Medical College; New York NY USA

8. Hamad Healthcare Quality Institute and Hamad Medical Corporation; Doha Qatar

Funder

National Institutes of Health

Merck

Valenant

AbbVie

Gilead Sciences

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

Reference35 articles.

1. Deaths: final data for 2009;Kochanek;Natl Vital Stat Rep,2011

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献